[en] G4 and p13(II) are accessory proteins encoded by the X region of bovine leukemia virus and human T-cell leukemia virus type 1 (HTLV-1), respectively. Disruption of the G4 and p13(II) open reading frames interferes with viral spread in animal model systems, indicating that the corresponding proteins play a key role in viral replication. In addition, G4 is oncogenic in primary cell cultures and is absolutely required for efficient onset of leukemogenesis in sheep. To gain insight into the function of these proteins, we utilized the yeast two-hybrid system to identify protein partners of G4. Results revealed that G4 interacts with farnesyl pyrophosphate synthetase (FPPS), a protein involved in the mevalonate/squalene pathway and in synthesis of FPP, a substrate required for prenylation of Ras. The specificity of the interaction was verified by glutathione S-transferase (GST) pull-down assays and by coimmunoprecipitation experiments. Furthermore, confocal microscopy showed that the subcellular localization of G4 was profoundly affected by FPPS. The G4 protein itself was not prenylated, at least in rabbit reticulocyte lysate-based assays. The domain of G4 required for binding to FPPS was restricted to an amphipathic alpha-helix rich in arginine residues. Subtle mutation of this alpha-helix abrogated G4 oncogenic potential in vitro, providing a biological relevance for FPPS-G4 complex formation in cells. Finally, HTLV-1 p13(II) was also found to specifically interact with FPPS (in yeast as well as in GST pull-down assays) and to colocalize with G4 in mitochondria, suggesting a functional analogy between these oncoviral accessory proteins. Identification of FPPS as a molecular partner for p13(II) and G4 accessory proteins opens retrovirus-induced leukemia.
Albrecht B., Collins N.D., Burniston M.T., Nisbet J.W., Ratner L., Green P.L., Lairmore M.D. (2000) Human T-lymphotropic virus type 1 open reading frame I p12I is required for efficient viral infectivity in primary lymphocytes. J. Virol. 74:9828-9835.
Alexandersen S., Carpenter S., Christensen J., Storgaard T., Viuff B., Wannemuehler Y., Belousov J., Roth J.A. (1993) Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus. J. Virol. 67:39-52.
Bartoe J., Albrecht B., Collins N., Robek M., Ratner L., Green P., Lairmore M. (2000) Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J. Virol. 74:1094-1100.
Beaupre D.M., Kurzrock R. (1999) Ras and leukemia: From basic mechanisms to gene-directed therapy. J. Clin. Oncol. 17:1071-1079.
Berneman Z.N., Gartenhaus R.B., Reitz Jr. M.S., Blattner W.A., Manns A., Hanchard B., Ikehara O., Gallo R.C., Klotman M.E. (1992) Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc. Natl. Acad. Sci. USA 89:3005-3009.
Cereseto A., Berneman Z., Koralnik I., Vaughn J., Franchini G., Klotman M.E. (1997) Differential expression of alternatively spliced pX mRNAs in HTLV-1-infected cell lines. Leukemia 11:866-870.
Chen Y.M., Chen S.H., Fu C.Y., Chen J.Y., Osame M. (1997) Antibody reactivities to tumor-suppressor protein p53 and HTLV-1 Tof, Rex and Tax in HTLV-1-infected people with differing clinical status. Int. J. Cancer 71:196-202.
Ciminale V., Pavlakis G.N., Derse D., Cunningham C.P., Felber B.K. (1992) Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: Novel mRNAs and proteins produced by HTLV type I. J. Virol. 66:1737-1745.
Ciminale V., D'Agostino D.M., Zotti L., Franchini G., Felber B.K., Chieco-Bianchi L. (1995) Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. Virology 209:445-456.
Ciminale V., D'Agostino D.M., Zotti L., Chieco-Bianchi L. (1996) Coding potential of the X region of human T-cell leukemia/lymphotropic virus type II. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13.
Ciminale V., Zotti L., D'Agostino D.M., Ferro T., Casareto L., Franchini G., Bernardi P., Chieco-Bianchi L. (1999) Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-1). Oncogene 18:4505-4514.
Collins N.D., Newbound G.C., Albrecht B., Beard J.L., Ratner L., Lairmore M.D. (1998) Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood 91:4701-4707.
Collins N.D., D'Souza C., Albrecht B., Robek M.D., Ratner L., Ding W., Green P.L., Lairmore M.D. (1999) Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expression. J. Virol. 73:9642-9649.
D'Agostino D.M., Ciminale V., Zotti L., Rosato A., Chieco-Bianchi L. (1997) The human T-cell lymphotropic virus type 1 T of protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex. J. Virol. 71:75-83.
Dekaban G.A., Peters A.A., Mulloy J.C., Johnson J.M., Trovato R., Rivadeneira E., Franchini G. (2000) The HTLV-1 OrfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits. Virology 274:86-93.
Derse D., Mikovits J., Ruscetti F. (1997) X-I and X-II open reading frames of HTLV-1 are not required for virus replication or for immortalization of primary T-cells in vitro. Virology 237:123-128.
Desagher S., Martinou J.C. (2000) Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10:369-377.
Franchini G., Mulloy J.C., Koralnik I.J., Lo Monico A., Sparkowski J.J., Andresson T., Goldstein D.J., Schlegel R. (1993) The human T-cell leukemia/lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase. J. Virol. 67:7701-7704.
Fu H.W., Casey P.J. (1999) Enzymology and biology of CaaX protein prenylation. Recent Prog. Horm. Res. 54:315-343.
Green P.L., Ross T.M., Chen I.S., Pettiford S. (1995) Human T-cell leukemia virus type II nucleotide sequences between env and the last exon of tax/rex are not required for viral replication or cellular transformation. J. Virol. 69:387-394.
Gupta S.D., Mehan R.S., Tansey T.R., Chen H.T., Goping G., Goldberg I., Shechter I. (1999) Differential binding of proteins to peroxisomes in rat hepatoma cells: Unique association of enzymes involved in isoprenoid metabolism. J. Lipid Res. 40:1572-1584.
Hou X., Foley S., Cueto M., Robinson M.A. (2000) The human T-cell leukemia virus type I (HTLV-1) X region encoded protein p13II interacts with cellular proteins. Virology 277:127-135.
Johnson J.M., Mulloy J.C., Ciminale V., Fullen J., Nicot C., Franchini G. (2000) The MHC class I heavy chain is a common target of the small proteins encoded by the 3′ end of HTLV type 1 and HTLV type 2. AIDS Res. Hum. Retrovir. 16:1777-1781.
Joly A., Edwards P.A. (1993) Effect of site-directed mutagenesis of conserved aspartate and arginine residues upon farnesyl diphosphate synthase activity. J. Biol. Chem. 268:26983-26989.
Keller R.K., Fliesler S.J. (1999) Mechanism of aminobisphosphonate action: Characterization of alendronate inhibition of the isoprenoid pathway. Biochem. Biophys. Res. Commun. 266:560-563.
Kerkhofs P., Heremans H., Burny A., Kettmann R., Willems L. (1998) In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein. J. Virol. 72:2554-2559.
Koralnik I.J., Gessain A., Klotman M.E., Lo Monico A., Berneman Z.N., Franchini G. (1992) Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I. Proc. Natl. Acad. Sci. USA 89:8813-8817.
Koralnik I.J., Fullen J., Franchini G. (1993) The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J. Virol. 67:2360-2366.
Koralnik I.J., Mulloy J.C., Andresson T., Fullen J., Franchini G. (1995) Mapping of the intermolecular association of human T cell leukaemia/lymphotropic virus type I p12I and the vacuolar H+-ATPase 16 kDa subunit protein. J. Gen. Virol. 76:1909-1916.
Krisans S.K., Ericsson J., Edwards P.A., Keller G.A. (1994) Farnesyl-diphosphate synthase is localized in peroxisomes. J. Biol. Chem. 269:14165-14169.
Lambert M.N., Bui D. (1999) Dexamethasone-induced decrease in HMG-CoA reductase protein-farnesyl transferase activities does not impair ras processing in AR 4-2J cells. Mol. Cell. Biochem. 202:101-108.
Marrero P.F., Poulter C.D., Edwards P.A. (1992) Effects of site-directed mutagenesis of the highly conserved aspartate residues in domain II of farnesyl diphosphate synthase activity. J. Biol. Chem. 267:21873-21878.
Matar P., Rosados V.R., Roggero E.A., Scharovsky O.G. (1998) Lovastatin inhibits tumor growth and metastasis development of rat fibrosarcoma. Cancer Biother. Radiopharm. 13:387-393.
Mulloy J.C., Crownley R.W., Fullen J., Leonard W.J., Franchini G. (1996) The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor β and γc chains and affects their expression on the cell surface. J. Virol. 70:3599-3605.
Ohnuma S.-I., Hirooka K., Ohto C., Nishino T. (1997) Conversion from archaeal geranylgeranyl diphosphate synthase to farnesyl diphosphate synthase. J. Biol. Chem. 272:5192-5198.
Pique C., Ureta-Vidal A., Gessain A., Chancerel B., Gout O., Tamouza R., Agis F., Dokhelar M.C. (2000) Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J. Exp. Med. 191:567-572.
Rao K.N. (1995) The significance of the cholesterol biosynthetic pathway in cell growth and carcinogenesis. Anticancer Res. 15:309-314.
Robek M.D., Wong F.H., Ratner L. (1998) Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes. J. Virol. 72:4458-4462.
Robek M.D., Ratner L. (1999) Immortalization of CD4+ and CD8+ T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J. Virol. 73:4856-4865.
Ross T.M., Pettiford S.M., Green P.L. (1996) The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes. J. Virol. 70:5194-5202.
Rowinsky E.K., Windle J.J., Von Hoff D.D. (1999) Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development. J. Clin. Oncol. 17:3631-3652.
Runquist M., Ericsson J., Thelin A., Chojnacki T., Dallner G. (1994) Isoprenoid biosynthesis in rat liver mitochondria. Studies on farnesyl pyrophosphate synthase and trans-prenyltransferase. J. Biol. Chem. 269:5804-5809.
Sagata N., Yasunaga T., Tsuzuku-Kawamura J., Ohishi K., Ogawa Y., Ikawa Y. (1985) Complete nucleotide sequence of the genome of bovine leukemia virus: Its evolutionary relationship to other retroviruses. Proc. Natl. Acad. Sci. USA 82:677-681.
Semmes O.J., Hammarskjold M.L. Molecular pathogenesis of HTLV-1: A current perspective, ABI Professional Publications, Arlington, Va; 1999.
Seymour L. (1999) Novel anti-cancer agents in development: Exciting prospects and new challenges. Cancer Treat. Rev. 25:301-312.
Song L., Poulter C.D. (1994) Yeast farnesyl-diphosphate synthase: Site-directed mutagenesis of residues in highly conserved prenyltransferase domains I and II. Proc. Natl. Acad. Sci. USA 91:3044-3048.
Schwartz S., Felber B.K., Benko D.M., Fënyo E.M., Pavlakis G.N. (1990) Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J. Virol. 64:2519-2529.
Tarshis L.C., Yan M., Poulter C.D., Sacchettini J.C. (1994) Crystal structure of recombinant farnesyl diphosphate synthase at 2.6-Å resolution. Biochemistry 33:10871-10877.
Trovato R., Mulloy J.C., Johnson J.M., Takemoto S., De Oliveira M.P., Franchini G. (1999) A lysine-to-arginine change found in natural alleles of the human T-cell lymphotropic/leukemia virus type 1 p12I protein greatly influences its stability. J. Virol. 73:6460-6467.
Webster N.J., Green S., Jin J.R., Chambon P. (1988) The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell 54:199-207.
Willems L., Heremans H., Chen G., Portetelle D., Billiau A., Burny A., Kettmann R. (1990) Cooperation between bovine leukemia virus transactivator protein and Ha-ras oncogene product in cellular transformation. EMBO J. 9:1577-1581.
Willems L., Kettmann R., Dequiedt F., Portetelle D., Vonèche V., Cornil I., Kerkhofs P., Burny A., Mammerickx M. (1993) In vivo infection of sheep by bovine leukemia virus mutants. J. Virol. 67:4078-4085.
Willems L., Kerkhofs P., Dequiedt F., Portetelle D., Mammerickx M., Burny A., Kettmann R. (1994) Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames. Proc. Natl. Acad. Sci. USA 91:11532-11536.
Willems L., Burny A., Collete D., Dangoisse O., Gatot J.S., Kerkhofs P., Lefebvre L., Merezak C., Portetene D., Twizere J.C., Kettmann R. (1999) Bovine leukemia virus as a model for human T-cell leukemia virus. Curr. Top. Virol. 1:139-167.
Willems L., Burny A., Collete D., Dangoisse O., Dequiedt F., Gatot J.S., Kerkhofs P., Lefebvre L., Merezak C., Peremans T., Twizere J.C., Kettmann R. (2000) Genetic determinants of bovine leukemia virus pathogenesis. AIDS Res. Hum. Retrovir. 16:1787-1795.
Zhang W., Nisbet J.W., Bartoe J.T., Ding W., Lairmore M.D. (2000) Human T-lymphotropic virus type 1 p30II functions as a transcription factor and differentially modulates CREB-responsive promoters. J. Virol. 74:11270-11277.
